Highest-materiality recent filing
Nutanix Q3 FY2026: ARR $2.43B (+15% YoY), revenue $703M (+10%), beats guidance, raises FY outlook
ARR grew 15% YoY to $2.43B; revenue $703M (+10% YoY), exceeding guided high end.
Nutanix closes $150M private placement of 4.14M shares to AMD at $36.26/shr
Sold 4,136,789 Class A common shares to AMD for aggregate cash proceeds of ~$150M.
Nutanix reports Q2 FY2026 revenue beat, announces $150M AMD investment and AI partnership
Q2 revenue $722.8M (+10% YoY); GAAP operating income $84.1M, ARR $2.36B (+16%).
Nutanix launches $300M accelerated share repurchase with Bank of America
ASR agreement to repurchase $300M of common stock; funded with existing cash.
Nutanix stockholders approve amended equity plan with fixed 19.5M share reserve
Stockholders approved a reduced, fixed share reserve of 19,500,000 shares, down from prior evergreen pool.
Nutanix Q1 FY2026: ARR $2.28B (+18% YoY); revenue $670.6M (+13%); raises FCF guidance
ARR $2.28B (+18% YoY); revenue $670.6M (+13% YoY); operating cash flow $196.8M.
Q4 revenue $653.3M (+19% YoY); FY revenue $2.54B (+18% YoY).
Nutanix director Brian Stevens resigns; Eric Brandt joins board
Brian Stevens resigned as director effective June 16, 2025; no disagreement.
Nutanix beats Q3 FY2025 guidance: ARR up 18% to $2.14B, revenue +22%
Revenue $639.0M (+22% YoY); GAAP operating income $48.6M vs loss of $11.6M a year ago.
Nutanix Q2 FY2025: ARR $2.06B (+19% YoY), Revenue $654.7M (+16% YoY), beat guidance
ARR grew 19% YoY to $2.06B; average contract duration 3.0 years (vs 2.8 years YoY).
Nutanix enters $500M senior secured revolving credit facility maturing 2030
Credit agreement dated Feb 12, 2025 provides $500M aggregate principal, including $25M letter-of-credit sublimit.
Net proceeds of ~$844.5M; used $95.5M to repurchase $75M of existing 2027 notes and $200M to buy back 3.1M shares at $64.78/share.
ARR reached $1.97B (+18% YoY); average contract duration 3.1 years (vs 2.9 years).
Nutanix sets FY2025 exec compensation; COO Sangster retires Oct 31
Rajiv Ramaswami base salary $800k, incentive 100% ($800k); RSUs 136,116 + PRSUs 136,116.
Nutanix Q4 ARR $1.91B (+22% YoY); first full year of positive GAAP operating income
Q4 revenue $548M (+11% YoY); ARR $1.91B (+22% YoY); ACV billings $338M (+21% YoY).
Nutanix Q3 FY2024: ARR $1.82B (+24% YoY), revenue $524.6M (+17%), beats guidance
ARR grew 24% YoY to $1.82B; ACV billings up 20% to $288.9M.
Nutanix Q2 FY24: Revenue $565M, ARR +26% YoY, first GAAP operating profit
ARR reached $1.74B, up 26% YoY; ACV billings $329.5M, up 23% YoY.
Nutanix grants CEO Rajiv Ramaswami performance-based RSUs with stock price and operational hurdles
Two tranches: 238,398 Stock Price PRSUs (target) and 327,083 Operational Metrics PRSUs (target).
Nutanix Q1 FY2024: ACV Billings +24% YoY to $287M; Non-GAAP OI $79.5M
ACV Billings $287.2M, up 24% YoY; ARR $1.66B, up 30% YoY.
Nutanix Q4 ACV billings up 44% YoY, revenue up 28%; $350M buyback authorized
Q4 ACV billings $278.7M (+44% YoY); ARR $1.56B (+30% YoY).
Corrected $10.2M RSU tax withholding error; reduces Q3 operating expenses by $9.3M, cost of revenue by $0.9M.
Nutanix Q3 FY2023 ACV Billings +17% YoY, completes audit probe, files Q2 10-Q
Q3 ACV Billings $239.8M (+17% YoY); ARR $1.47B (+32%); Revenue $448.6M (+11%).
Nutanix reports Q2 ACV billings up 23% YoY, but delays 10-Q due to software license investigation
ACV Billings $267.6M (+23% YoY); ARR $1.38B (+32%); Revenue $486.5M (+18%).
Nutanix Q1 FY23: ACV billings +27% YoY, first positive non-GAAP operating income
ACV Billings $231.9M (+27% YoY), ARR $1.28B (+34% YoY), revenue $433.6M (+15% YoY).
Nutanix to declassify board, adopt majority voting, remove supermajority provisions
Board will seek stockholder approval to declassify, moving to annual director elections by 2025.
Nutanix Q4 ACV Billings up 10% YoY, reports positive free cash flow of $23.2M
Q4 ACV Billings $193.2M (+10% YoY); full-year $756.3M (+27%).
Nutanix cuts ~4% of workforce; expects $20-25M charge in Q1 FY23
Approximately 270 employees (~4% of workforce) to be let go as part of cost-cutting drive.
Nutanix appoints Andrew Brinded as CRO, updates FY2022 outlook upward
Andrew Brinded appointed CRO effective immediately, replacing Dominick Delfino who stepped down to pursue another opportunity.
ACV billings $204.7M (+28% YoY); ARR $1.1B (+46% YoY); revenue $403.7M (+17% YoY).
Nutanix appoints Rukmini Sivaraman as CFO; reaffirms FY2022 guidance
Duston Williams resigns as CFO effective 4/30/22 to become CFO of a pre-IPO company; no disagreement with Nutanix.
Nutanix Q2 FY2022: Revenue up 19% to $413.1M, ACV billings +37%
ACV billings $217.9M (+37% YoY); ARR $1.04B (+55% YoY).
On June 14, 2025, Brian Stevens submitted his resignation as a director of Nutanix, Inc. (the “Company”), effective as of June 16, 2025.
Additionally, David Humphrey resigned from Nutanix’s board of directors, effective May 15, 2025.
Nutanix (NASDAQ: NTNX ), a leader in hybrid multicloud computing, announced today that it has added Eric K. Brandt to its board of directors, effective May 15, 2025.
David Humphrey submitted his resignation as a director, effective as of May 15, 2025.
appointed Eric K. Brandt as a director.
David Sangster, Chief Operating Officer of Nutanix, Inc. (the “Company”), notified the Company of his decision to retire as Chief Operating Officer, effective October 31, 2024.
On February 6 , 2024, Tyler Wall, Chief Legal Officer of Nutanix, Inc. (the “Company”), notified the Company of his decision to retire as Chief Legal Officer.
appointed Mark Templeton as a Class I director
On March 30, 2022, Susan L. Bostrom, who currently serves as a Class I director of the Board of Directors (the “Board”) of Nutanix, Inc. (the “Company”), resigned from the Board, effective as of such date.
appointed Gayle Sheppard as a Class III director
Max materiality 0.90 · Median 0.65 · Most common event earnings